Search

Your search keyword '"Herold-Mende, Ch."' showing total 9 results
Start Over Author "Herold-Mende, Ch."
9 results on '"Herold-Mende, Ch."'

2. Differential DNA methylation in long-term surviving GBM patients

Author

Mock, A, Warta, R, Schmezer, P, Plass, C, Herold-Mende, CH, and Unterberg, A

Subjects
Methylierung, Langzeitüberleben, ddc: 610, glioblastoma, methylation, 610 Medical sciences, Medicine, Glioblastom, long-term survival
Abstract

Objective: Despite unfavorable diagnosis, 3–5% of glioblastoma patients show long-term survival of 36 months or longer after diagnosis. Recent publications indicate that this survival benefit bases on altered gene expression. Epigenetic modifications, e.g. DNA methylation are known to be[for full text, please go to the a.m. URL], 63. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie (JNS)

Published
2012
Full Text
View/download PDF

3. Development of a GBM vaccine based on HLA-A2-associated peptides

Author

Herold-Mende, CH, Dutoit, V, Beckhove, P, Dietrich, PY, Singh-Jasuja, HS, and Unterberg, A

Subjects
Immuntherapie, ddc: 610, vaccine, glioblastoma, Immunotherapy, 610 Medical sciences, Medicine, Glioblastom
Abstract

Objective: Cancer vaccines are an attractive alternative to standard cancer treatments and are already being tested in humans. Ideally, T-cell-mediated tumor immunotherapy is directed against several tumor-associated antigens in order to circumvent the so called 'immune escape'. Methods:[for full text, please go to the a.m. URL], 63. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie (JNS)

Published
2012
Full Text
View/download PDF

4. Genexpression von Plattenepithelkarzinomen nach anti-angiogene Therapie im Mausmodell

Author

Vasvari, Gergely P., Dyckhoff, G., Beckhove, P., Sültmann, H., Lemke, B., Herold-Mende, Ch., and Plinkert, P. K.

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Eine Kombinationstherapie mit Thalidomid und metronomisch appliziertem Cisplatin zeigte in einem Mausmodell von Kopf-Hals-Karzinomen (HNSCC) antiproliferative und anti-angiogene Effekte. Über die molekularen Wirkmechanismen ist allerdings wenig bekannt. Das Ziel unserer Untersuchungen war es, therapieregulierte[for full text, please go to the a.m. URL], 93. Jahrestagung der Vereinigung Südwestdeutscher Hals-Nasen-Ohrenärzte

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results